The diagnostic value of pepsin concentration in saliva for laryngopharyngeal reflux disease.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 06 01 2022
accepted: 27 05 2022
pubmed: 12 6 2022
medline: 15 11 2022
entrez: 11 6 2022
Statut: ppublish

Résumé

To explore the diagnostic efficacy of pepsin concentration in saliva for laryngopharyngeal reflux (LPR) disease. In this study, we recruited 40 participants with abnormal sensation of throat into the study who visited our hospital from March 2020 to December 2020. The 24 h multichannel intraluminal impedance and pH monitoring (24 h MII-pH), reflux symptom index (RSI) and reflux finding score (RFS), pepsin concentration in saliva were collected. The Cohen's kappa test and receiver-operating characteristic (ROC) curves were performed to determine and compare the sensitivity and specificity of five diagnostic methods: RSI; RFS, pepsin concentration, RSI + RFS, RSI + RFS + pepsin concentration. The area under the curve (AUC) of RSI, RFS, pepsin concentration, RSI + RFS, RSI + RFS + pepsin concentration were 0.767, 0.733, 0.870, 0.750,0.867, respectively. That is, the pepsin concentration has maximum AUC (the cutoff point is 219.47 (ng/mL); the sensitivity and 1-specificity is 0.300, 0.933, respectively.). The positive predictive value was 90.3% (28/31), and the negative predictive value was 77.8% (7/9). The Cohen's kappa coefficients of the five diagnostic subgroups were: RSI 0.486 (95% CI 0.207-0.764, P = 0.001); RFS 0.333 (95% CI 0.021-0.644, P = 0.032); RSI + RFS: 0.517 (95% CI 0.205-0.829, P = 0.001); pepsin concentration: 0.699 (95% CI 0.379-0.931, P = 0.001); RSI + RFS + pepsin concentration: 0.500 (95% CI 0.181-0.819, P < 0.001). The pepsin concentration has the maximum AUC area and highest consistency with the 24 h MII-pH. Therefore, it has certain value in the screening and diagnosis of diseases related to LPR disease.

Identifiants

pubmed: 35689682
doi: 10.1007/s00405-022-07472-x
pii: 10.1007/s00405-022-07472-x
doi:

Substances chimiques

Pepsin A EC 3.4.23.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5783-5789

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Lechien JR, Saussez S, Schindler A et al (2019) Clinical outcomes of laryngopharyngeal reflux treatment: a systematic review and meta-analysis. Laryngoscope 129(5):1174–1187
doi: 10.1002/lary.27591
Mccormick CA, Samuels TL, Battle MA et al (2020) H+/K+ATPase expression in the larynx of laryngopharyngeal reflux and laryngeal cancer patients. Laryngoscope 131(1):130–135
doi: 10.1002/lary.28643
Lechien JR, Saussez S, Nacci A et al (2019) Association between laryngopharyngeal reflux and benign vocal folds lesions: a systematic review. Laryngoscope 129(9):E329–E341
doi: 10.1002/lary.27932
Kakaje A, Alhalabi MM, Alyousbashi A et al (2021) Allergic rhinitis, asthma and laryngopharyngeal reflux disease: a cross-sectional study on their reciprocal relations. Sci Rep 11(1):2870
doi: 10.1038/s41598-020-80793-1
Knight J, Lively MO, Johnston N et al (2005) Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 115(8):1473–1478
doi: 10.1097/01.mlg.0000172043.51871.d9
Branski RC, Neil B, Jo S (2010) The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 112(6):1019–1024
doi: 10.1097/00005537-200206000-00016
Ocak E, Kubat G, Yorulmaz I (2015) Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux. Balkan Med J 32(1):46
doi: 10.5152/balkanmedj.2015.15824
Iannella G, Vicini C, Polimeni A et al (2019) Laryngopharyngeal reflux diagnosis in obstructive sleep apnea patients using the pepsin salivary test. Int J Environ Res Public Health 16(11):2056
doi: 10.3390/ijerph16112056
Reichel O, Issing WJ (2008) Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux. J Laryngol Otol 122(05):485–489
doi: 10.1017/S0022215107008390
Chinese Journal of Otolaryngology-Head and Neck Surgery Editorial Board Throat Group, Chinese Medical Association Otolaryngology-Head and Neck Surgery Branch Pharyngology Group (2016) Expert consensus on diagnosis and treatment of laryngopharyngeal reflux disease (2015). Chin J Otolaryngol Head Neck Surg 51(5):324–326 (6)
Numans ME, Lau J, Wit N et al (2004) Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 140(7):518
doi: 10.7326/0003-4819-140-7-200404060-00011
Michael F, Alexander M, Kanwar K et al (2011) Impact of pH monitoring on laryngopharyngeal reflux treatment: improved compliance and symptom resolution. Otolaryngol Head Neck Surg 144(4):558–562
doi: 10.1177/0194599811399240
Wang S (2019) A meta-analysis of long-term use of proton pump inhibitors and the risk of gastric cancer. Jilin University, Changchun
Vaezi MF, Richter JE, Stasney CR et al (2006) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116(2):254–260
doi: 10.1097/01.mlg.0000192173.00498.ba
Wise JL, Murray JA (2010) Utilising multichannel intraluminal impedance for diagnosing GERD: a review. Dis Esophagus 20(2):83–88
doi: 10.1111/j.1442-2050.2007.00654.x
Samuels TL, Johnston N (2009) Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg 141(5):175–175
doi: 10.1016/j.otohns.2009.06.555
Jiang A, Liang M, Su Z et al (2011) Immunohistochemical detection of pepsin in laryngeal mucosa for diagnosing laryngopharyngeal reflux. Laryngoscope 121(7):1426–1430
doi: 10.1002/lary.21809
Weitzendorfer M, Antoniou SA, Schredl P et al (2020) Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux. Laryngoscope 130(7):1780–1786
doi: 10.1002/lary.28320
Wang CP, Wang CC (2019) Saliva pepsin detection and proton pump inhibitor response in suspected laryngopharyngeal reflux. Laryngoscope 129(3):709–714
doi: 10.1002/lary.27502
Zeleník K, Hránková V, Vrtková A (2021) Diagnostic value of the Peptest(TM) in detecting laryngopharyngeal reflux. J Clin Med 10(13):2996
doi: 10.3390/jcm10132996
Lechien JR, Bobin F, Dequanter D et al (2021) Does pepsin saliva concentration (Peptest) predict the therapeutic response of laryngopharyngeal reflux patients? Ann Otol Rhinol Laryngol 130(9):996–1003
doi: 10.1177/0003489420986347
Calvo-Henríquez C, Ruano-Ravina A, Vaamonde P et al (2017) Is pepsin a reliable marker of laryngopharyngeal reflux? A systematic review. Otolaryngol Head Neck Surg 157(3):385–391
doi: 10.1177/0194599817709430
Bobin F, Journe F, Lechien JR (2020) Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes. Laryngoscope 130(5):1278–1281
doi: 10.1002/lary.28260
Ryu IY, Jung AR, Park JM et al (2017) Comparison of methods for collecting saliva for pepsin detection in patients with laryngopharyngeal reflux. Korean J Otorhinolaryngol Head Neck Surg 60(11):570–574
doi: 10.3342/kjorl-hns.2017.00451
Na SY, Kwon OE, Lee YC et al (2016) Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux. Laryngoscope 126(12):2770–2773
doi: 10.1002/lary.26018
Jinrang Li, Shiyu T, Shizhen Z et al (2017) Application of pepsin content determination in saliva of healthy adults in auxiliary detection of laryngopharyngeal reflux. Chin J Gastroesophageal Reflux Dis 4(1):7–10
Meixiang C, Chenjie H, Ting C et al (2018) Analysis of salivary pepsin content and laryngopharyngeal reflux scale score in 91 asymptomatic volunteers. J Clin Otolaryngol Head Neck Surg 32(6):415–419
Merati AL, Ulualp SO, Lim HJ et al (2005) Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 114(3):177–182
doi: 10.1177/000348940511400302
Wo JM, Goudy S, Winstead W et al (2003) Lifestyle and dietary modification as the primary therapy for laryngopharyngeal reflux. Gastroenterology 124(4):540–540
doi: 10.1016/S0016-5085(03)82732-4
Lechien JR, Kumar R, Chiesa-Estomba CM (2020) Laryngopharyngeal reflux and autonomic nerve dysfunction: what about stress? Eur Arch Otorhinolaryngol 277(10):2937–2938
doi: 10.1007/s00405-019-05567-6
Divakaran S, Rajendran S, Thomas RM et al (2021) Laryngopharyngeal reflux: symptoms, signs, and presence of pepsin in saliva—a reliable diagnostic triad. Int Arch Otorhinolaryngol 25(2):273–278
doi: 10.1055/s-0040-1709987

Auteurs

Lei Yu (L)

Department of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Rui Li (R)

Department of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Linnan Du (L)

Chemical Engineering Institute, Shijiazhuang University, Shijiazhuang, China.

Yuliang Zhao (Y)

Department of Otorhinolaryngology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China. 624602085@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH